Fumery, M., Defrance, A., Roblin, X., Altwegg, R., Caron, B., Hebuterne, X., Carmen, S., Meyer, A., Nachury, M., Laharie, D., Nancey, S., Le Berre, C., Serrero, M., Geyl, S., Gilletta, C., Ah Soune, P., Duveau, N., Uzza, M., Abitbol, V., Biron, A., Tran Minh, M. L., Paupard, T., Vuitton, L., Elgharabawy, Y., Peyrin-biroulet, L., & , (n.d.). p638 Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study. Journal of Crohn's and colitis, 17, i770. http://access.bl.uk/ark:/81055/vdc_100179843796.0x000008